Back
Norfolk Southern 10K Form
Buy
54
NSC
Norfolk Southern
Last Price:
$247.80
Seasonality Move:
3.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-24 | 10Q | NSC/Norfolk Southern Quarterly |
2024-02-05 | 10K | NSC/Norfolk Southern Annual |
2023-10-25 | 10Q | NSC/Norfolk Southern Quarterly |
2023-07-27 | 10Q | NSC/Norfolk Southern Quarterly |
2023-04-26 | 10Q | NSC/Norfolk Southern Quarterly |
2023-02-03 | 10K | NSC/Norfolk Southern Annual |
Receive NSC News And Ratings
See the #1 stock for the next 7 days that we like better than NSC
NSC Financial Statistics
Sales & Book Value
Annual Sales: | $12.1B |
---|---|
Cash Flow: | $276M |
Price / Cash Flow: | 33.58 |
Annual Sales: | $63.21 |
Price / Book: | 3.92 |
Profitability
EPS (TTM): | 11.56000 |
---|---|
Net Income (TTM): | $2.6B |
Gross Margin: | $4.5B |
Return on Equity: | 19.75% |
Return on Assets: | 6.15% |
Norfolk Southern Earnings Forecast
Key Norfolk Southern Financial Ratios
-
The Gross Profit Margin over the past 41 years for NSC is 37.47%.
-
The Selling, General & Administrative Expenses for NSC have been equal to -0.14% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 30.78% of Operating Income.
-
The Net Earning history of NSC is 21.63% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 26 years.
Norfolk Southern Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Ground Transportation |
Sector: | Industrials |
Current Symbol: | NSC |
CUSIP: | 655844 |
Website: | norfolksouthern.com |
Debt
Debt-to-Equity Ratio: | 1.2 |
---|---|
Current Ratio: | 0.9 |
Quick Ratio: | 0.76 |
Price-to-Earnings
Trailing P/E Ratio: | 21.41 |
---|---|
Forward P/E Ratio: | 16.65 |
NSC Technical Analysis vs Fundamental Analysis
Buy
54
Norfolk Southern (NSC)
is a Buy
Is Norfolk Southern a Buy or a Sell?
-
Norfolk Southern stock is rated a BuyThe current Norfolk Southern [NSC] share price is $247.76. The Score for NSC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.